The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 350:302-303 January 15, 2004 Number 3
NextNext

Cross-Reactivity and Sulfonamide Antibiotics

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Strom, B. L.
-PubMed Citation
To the Editor: The article by Strom et al. (Oct. 23 issue)1 suffers from the classic shortcomings of retrospective studies of adverse drug reactions and particularly from the use of the term "allergic" to describe a myriad of outcomes grouped together as allergic drug reactions. The authors' broad definition of hypersensitivity or allergic reactions (in Supplementary Appendix 1) includes an "unspecified adverse effect of a drug, medicinal agent, or biologic substance" and introduces so much noise that the results are essentially useless clinically. Even their "narrow definition" includes highly diverse immunologic and nonimmunologic outcomes. True immunologic reactions will be swamped . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.